30 April 2020

Safety Updates & Recalls of Pharmaceutical Products

Reference: CIR-2019-00000329

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Recall four batchs of Pharmaceutical product PRE-TAT Superior Pain & Itch relief & smoothing sore relief cream & gel product
• Safety update of pharmaceutical product while dispensing Gilenya (fingolimod)
• Voluntary recall for pharamecutical product Relpax (eletriptan hydrobromide ) 40mg tablet
• Warning from using medical product iLA activve kits iLA activve iLA kit -Xenios-
• Warning from using medical product MAGEC System

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Warning from using medical product MAGEC System.pdf:

View Document

Warning from using medical product iLA activve kits iLA activve iLA kit -Xenios-.pdf:

View Document

Voluntary recall for pharamecutical product Relpax (eletriptan hydrobromide ) 40mg tablet.pdf:

View Document

Safety update of pharmaceutical product while dispensing Gilenya (fingolimod).pdf:

View Document

Recall four batchs of Pharmaceutical product PRE-TAT Superior Pain _ Itch relief _ smoothing sore relief cream _ gel product.pdf:

View Document